Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study

BACKGROUND: Metagenomic next-generation sequencing of microbial cell-free DNA (mcfDNA) allows for non-invasive pathogen detection from plasma. However, there is little data describing the optimal role for this assay in real-world clinical decision making. METHODS: We performed a single-center retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Shishido, Akira A., Noe, Myint, Saharia, Kapil, Luethy, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006594/
https://www.ncbi.nlm.nih.gov/pubmed/35418022
http://dx.doi.org/10.1186/s12879-022-07357-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006594/
https://www.ncbi.nlm.nih.gov/pubmed/35418022
http://dx.doi.org/10.1186/s12879-022-07357-8

Ejemplares similares